Literature DB >> 23873315

Management of secondary immune deficiencies: what is the role of immunoglobulins?

Luc Mouthon1, Jean-Paul Fermand, Jacques-Eric Gottenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23873315     DOI： 10.1097/01.all.0000433132.16436.b5

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN： 1473-6322


× No keyword cloud information.
  4 in total

Review 1.  A Canadian perspective on the use of immunoglobulin therapy to reduce infectious complications in chronic lymphocytic leukemia.

Authors:  S Lachance; A L Christofides; J K Lee; L H Sehn; B C Ritchie; C Shustik; D A Stewart; C L Toze; E Haddad; D C Vinh
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

Review 2.  Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.

Authors:  Jacqueline Kerr; Isabella Quinti; Martha Eibl; Helen Chapel; Peter J Späth; W A Carrock Sewell; Abdulgabar Salama; Ivo N van Schaik; Taco W Kuijpers; Hans-Hartmut Peter
Journal:  Front Immunol       Date:  2014-12-12       Impact factor: 7.561

3.  A clinician survey for management of the secondary immunodeficiency caused by hematological malignancies in China.

Authors:  Chunmei Ye; Juan Liu; Xiaolu Song; Sujie Zheng; Jinlin Liu
Journal:  Medicine (Baltimore)       Date:  2021-01-22       Impact factor: 1.889

4.  Primary vs. secondary antibody deficiency: clinical features and infection outcomes of immunoglobulin replacement.

Authors:  Sai S Duraisingham; Matthew Buckland; John Dempster; Lorena Lorenzo; Sofia Grigoriadou; Hilary J Longhurst
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.